US pharmaceutical giant Merck & Co will break into the South African market with the help of the country’s biggest over-the-counter drugs company Adcock Ingram Holdings Ltd.
Medicines for migraines, asthma and high blood pressure among other ailments will be produced, the drugmaker from New Jersey said. The financial details of the partnership have not been revealed.
A quarter of all the sales of its drugs and vaccines will be from developing countries by 2013, Merck expects.
After France’s Sanofi-Aventis SA, Merck has the second-biggest share of the market in Latin America. It has increased the size of its Chinese sales force by 90% to 3,000 employees.
“We will strive to expand our presence across emerging markets by actively seeking local collaborations,” Stefan Oschmann, Merck’s president of emerging markets, said.
Copyright Press Association 2010